Microangiopathy in patients with chronic myelogenous leukemia treated with interferon.
Creutzig
A
A
Department of Angiology, Medizinische Hochschule, Hannover, Germany.
Freund
M
M
Caspary
L
L
Alexander
K
K
D000328:Adult; D000368:Aged; D002196:Capillaries / Q000503:physiopathology; D005260:Female; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008833:Microcirculation / Q000503:physiopathology*; D008875:Middle Aged; D011928:Raynaud Disease / Q000139:chemically induced* / Q000503:physiopathology; D011994:Recombinant Proteins
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins